Literature DB >> 11781376

Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor.

Wassim Y Almawi1, Ohannes K Melemedjian.   

Abstract

Glucocorticoids (GCs) exert their anti-inflammatory and immunosuppressive effects by inhibiting the expression of cytokines and adhesion molecules. The molecular basis of GC action lies in their capacity to diffuse through the cell membrane and bind their cytosolic GC receptor (GR), which subsequently undergoes nuclear translocation and modulates transcriptional activation through association with promoter elements, GC response elements (GRE). GR also antagonized the activity of transcription factors, including NF-kappa B, NF-AT, and AP-1, through direct and indirect mechanisms. GCs induced the gene transcription and protein synthesis of the NF-kappa B inhibitor, I kappa B. Activated GR antagonized transcription factor activity through protein:protein interaction. This involved complexing with and inhibition of transcription factor binding to DNA (simple model), association with factor bound at its DNA site (composite model), and/or through interaction of GRE-bound GR with DNA-bound transcription factor (transmodulation model). Finally, GR competed with transcription factors for nuclear coactivators (competition model), including CBP and p300. Remarkably, GR did not affect the assembly of the preinitiation complex but acted proximally in inhibiting transcription factor activity and thus transcriptional initiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781376

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  40 in total

Review 1.  MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.

Authors:  Sara De Iudicibus; Marianna Lucafò; Stefano Martelossi; Chiara Pierobon; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 2.  Scientific and clinical challenges in sepsis.

Authors:  Luis Ulloa; Michael Brunner; Laura Ramos; Edwin A Deitch
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

3.  Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.

Authors:  Raymond M Schiffelers; Josbert M Metselaar; Marcel H A M Fens; Adriënne P C A Janssen; Grietje Molema; Gert Storm
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

Review 4.  Implications of glucocorticoid therapy in idiopathic inflammatory myopathies.

Authors:  Beatriz Y Hanaoka; Charlotte A Peterson; Craig Horbinski; Leslie J Crofford
Journal:  Nat Rev Rheumatol       Date:  2012-06-12       Impact factor: 20.543

5.  Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling.

Authors:  Kathleen Smoak; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

6.  Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells.

Authors:  Megan E Cavet; Karen L Harrington; Keith W Ward; Jin-Zhong Zhang
Journal:  Mol Vis       Date:  2010-09-02       Impact factor: 2.367

7.  Glucocorticoid receptor (GR) immunohistochemical expression is correlated with cell cycle-related molecules in human colon cancer.

Authors:  Stamatios Theocharis; Gregorios Kouraklis; Alexandra Margeli; Emmanuel Agapitos; Sotirios Ninos; Gabriel Karatzas; Antonios Koutselinis
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

8.  Endothelial nuclear lamina is not required for glucocorticoid receptor nuclear import but does affect receptor-mediated transcription activation.

Authors:  Arman Nayebosadri; Julie Y Ji
Journal:  Am J Physiol Cell Physiol       Date:  2013-05-22       Impact factor: 4.249

Review 9.  Role of the hypothalamic-pituitary-adrenal axis in developmental programming of health and disease.

Authors:  Fuxia Xiong; Lubo Zhang
Journal:  Front Neuroendocrinol       Date:  2012-11-27       Impact factor: 8.606

10.  Prostaglandin treatment is associated with a withdrawal of progesterone and androgen at the receptor level in the uterine cervix.

Authors:  Ylva Vladic-Stjernholm; Tomislav Vladic; Chellakkan S Blesson; Gunvor Ekman-Ordeberg; Lena Sahlin
Journal:  Reprod Biol Endocrinol       Date:  2009-10-23       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.